The third affiliated hospital of Shandong first medical university, Jinan, Shandong, China.
Guangxi Medical University, Nanning, Guangxi, China.
BMC Cardiovasc Disord. 2020 Sep 29;20(1):426. doi: 10.1186/s12872-020-01696-7.
Previous studies focus on one or several serum biomarkers and the risk of cardiovascular disease (CVD). This study aims to investigate the association of multiple serum biomarkers and the risk of CVD and evaluate the dose-relationship between a single serum metabolite and CVD.
Our case-control study included 161 CVD and 160 non-CVD patients who had a physical examination in the same hospital. We used stratified analysis and cubic restricted analysis to investigate the dose-response relationship of individual serum biomarkers and the CVD incident. Moreover, to investigate serum biomarkers and CVD, we used elastic net regression and logistic regression to build a multi-biomarker model.
In a single serum biomarker model, we found serum FT4, T4. GLU, CREA, TG and LDL-c were positively associated with CVD. In the male group, serum T4, GLU and LDL-c were positively associated with CVD; and serum TG was positively associated with CVD in the female group. When patients ≤63 years old, serum T4, GLU, CREA and TG were positively associated with CVD, and serum TG and LDL-c were positively associated with CVD when patients > 63 years old. Moreover, serum GLU had nonlinearity relationship with CVD and serum TG and LDL-c had linearity association with CVD. Furthermore, we used elastic regression selecting 5 serum biomarkers (GLU, FT4, TG, HDL-c, LDL-c) which were independently associated with CVD incident and built multi-biomarker model. And the multi-biomarker model had much better sensitivity than single biomarker model.
The multi-biomarker model had much higher sensitivity than a single biomarker model for the prediction of CVD. Serum FT4, TG and LDL-c were positively associated with the risk of CVD in single and multiple serum biomarkers models, and serum TG and LDL-c had linearity relationship with CVD.
之前的研究集中在一个或几个血清生物标志物与心血管疾病 (CVD) 的风险上。本研究旨在探讨多种血清生物标志物与 CVD 风险的关系,并评估单个血清代谢物与 CVD 之间的剂量关系。
我们的病例对照研究纳入了 161 例 CVD 患者和 160 例非 CVD 患者,这些患者在同一家医院进行了体检。我们使用分层分析和三次限制分析来研究个体血清生物标志物与 CVD 事件的剂量反应关系。此外,为了研究血清生物标志物与 CVD 的关系,我们使用弹性网络回归和逻辑回归构建了一个多生物标志物模型。
在单个血清生物标志物模型中,我们发现血清 FT4、T4、GLU、CREA、TG 和 LDL-c 与 CVD 呈正相关。在男性组中,血清 T4、GLU 和 LDL-c 与 CVD 呈正相关;而在女性组中,血清 TG 与 CVD 呈正相关。当患者≤63 岁时,血清 T4、GLU、CREA 和 TG 与 CVD 呈正相关,而当患者>63 岁时,血清 TG 和 LDL-c 与 CVD 呈正相关。此外,血清 GLU 与 CVD 呈非线性关系,而血清 TG 和 LDL-c 与 CVD 呈线性关系。此外,我们使用弹性回归选择了 5 个与 CVD 事件独立相关的血清生物标志物(GLU、FT4、TG、HDL-c、LDL-c),并构建了多生物标志物模型。而且,多生物标志物模型的敏感性明显高于单个生物标志物模型。
多生物标志物模型在预测 CVD 方面的敏感性明显高于单个生物标志物模型。在单个和多个血清生物标志物模型中,血清 FT4、TG 和 LDL-c 与 CVD 风险呈正相关,且血清 TG 和 LDL-c 与 CVD 呈线性关系。